Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan B Packard

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|December 6, 2012
Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET)Mark D Bartholomä, Vijay Gottumukkala, Shaohui Zhang, et al.
Magnetic Resonance Imaging|October 4, 2005
On the strong field dependence and nonlinear response to gadolinium contrast agent of proton transverse relaxation rates in dairy creamRobert V Mulkern, Yin P Hung, Zaid Ababneh, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|November 18, 2014
Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphineAnna W Sromek, Shaohui Zhang, Vamsidhar Akurathi, et al.
Nuclear Medicine and Biology|July 25, 2015
(18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodaminesMark D Bartholomä, Shaohui Zhang, Vamsidhar Akurathi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2012
64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanomaAmy L Vavere, Elizabeth R Butch, Jason L J Dearling, et al.
Nuclear Medicine and Biology|September 10, 2013
Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracerMark D Bartholomä, Huamei He, Christina A Pacak, et al.
Inflammatory Bowel Diseases|February 27, 2010
Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibodyJason L J Dearling, Eun Jeong Park, Patricia Dunning, et al.
Nuclear Medicine and Biology|May 25, 2013
Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumorsJason L J Dearling, Jessica W Barnes, Dipak Panigrahy, et al.
Nuclear Medicine and Biology|January 12, 2011
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibodyJason L J Dearling, Stephan D Voss, Patricia Dunning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 23, 2014
Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zincTimothy R DeGrado, Mukesh K Pandey, John F Byrne, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|December 6, 2012
Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET)Mark D Bartholomä, Vijay Gottumukkala, Shaohui Zhang, et al.
Magnetic Resonance Imaging|October 4, 2005
On the strong field dependence and nonlinear response to gadolinium contrast agent of proton transverse relaxation rates in dairy creamRobert V Mulkern, Yin P Hung, Zaid Ababneh, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|November 18, 2014
Convenient synthesis of 18F-radiolabeled R-(-)-N-n-propyl-2-(3-fluoropropanoxy-11-hydroxynoraporphineAnna W Sromek, Shaohui Zhang, Vamsidhar Akurathi, et al.
Nuclear Medicine and Biology|July 25, 2015
(18)F-labeled rhodamines as potential myocardial perfusion agents: comparison of pharmacokinetic properties of several rhodaminesMark D Bartholomä, Shaohui Zhang, Vamsidhar Akurathi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2012
64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanomaAmy L Vavere, Elizabeth R Butch, Jason L J Dearling, et al.
Nuclear Medicine and Biology|September 10, 2013
Biological characterization of F-18-labeled rhodamine B, a potential positron emission tomography perfusion tracerMark D Bartholomä, Huamei He, Christina A Pacak, et al.
Inflammatory Bowel Diseases|February 27, 2010
Detection of intestinal inflammation by MicroPET imaging using a (64)Cu-labeled anti-beta(7) integrin antibodyJason L J Dearling, Eun Jeong Park, Patricia Dunning, et al.
Nuclear Medicine and Biology|May 25, 2013
Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumorsJason L J Dearling, Jessica W Barnes, Dipak Panigrahy, et al.
Nuclear Medicine and Biology|January 12, 2011
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibodyJason L J Dearling, Stephan D Voss, Patricia Dunning, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 23, 2014
Preparation and preliminary evaluation of 63Zn-zinc citrate as a novel PET imaging biomarker for zincTimothy R DeGrado, Mukesh K Pandey, John F Byrne, et al.
Pageof 6